Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Breast Neoplasms and TLR9[original query] |
---|
Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer. Genetic testing and molecular biomarkers 2009 Dec 13 (6): 729-34. Etokebe Godfrey E, Knezevi? Jelena, Petricevi? Branka, Paveli? Jasminka, Vrbanec Damir, Dembi? Zlat |
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study. BMC cancer 2013 13 (1): 219. Resler Alexa J, Malone Kathleen E, Johnson Lisa G, Malkki Mari, Petersdorf Effie W, McKnight Barbara, Madeleine Margaret |
Associations between TLR9 polymorphisms and cancer risk: evidence from an updated meta-analysis of 25,685 subjects. Asian Pacific journal of cancer prevention : APJCP 2014 15 (19): 8279-85. Wan Guo-Xing, Cao Yu-Wen, Li Wen-Qin, Li Yu-Cong, Zhang Wen-Jie, Li Fe |
Toll-like receptor gene polymorphisms and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma in Northern China. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 0 21 (2): 95-103. Liu Shuzhen, Wang Xiaofeng, Shi Yuanyuan, Han Lu, Zhao Zhenzhen, Zhao Chengquan, Luo Bi |
Polymorphisms of glutathione S-transferase p 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility. Oncology letters 2016 Mar 11 (3): 2182-2188. Al-Harras Mohammad F, Houssen Maha E, Shaker Mohamed E, Farag Kamel, Farouk Omar, Monir Rehan, El-Mahdy Rasha, Abo-Hashem Ekbal |
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans. PloS one 2017 12 (9): e0183832. Chandler Madison R, Keene Kimberly S, Tuomela Johanna M, Forero-Torres Andres, Desmond Renee, Vuopala Katri S, Harris Kevin W, Merner Nancy D, Selander Katri |
TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-?B Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response. Molecular pharmacology 2017 08 92 (2): 175-184. Ho Ming-Fen, Ingle James N, Bongartz Tim, Kalari Krishna R, Goss Paul E, Shepherd Lois E, Mushiroda Taisei, Kubo Michiaki, Wang Liewei, Weinshilboum Richard |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: